首页|期刊导航|中医杂志(英文版)|Berberine alleviates alcoholic liver disease via activating intestinal nuclear receptor subfamily 1 group D member 1

Berberine alleviates alcoholic liver disease via activating intestinal nuclear receptor subfamily 1 group D member 1OA

Berberine alleviates alcoholic liver disease via activating intestinal nuclear receptor subfamily 1 group D member 1

HUANG Yuwei;CAI Yuting;LI Zanjin;WU Zicong;GUO Lianxia;LIN Luomin;DONG Linlin;WU Baojian;DONG Dong

Institute of Molecular Rhythm and Metabolism,Guangzhou University of Chinese Medicine,Guangzhou 510000,ChinaInstitute of Molecular Rhythm and Metabolism,Guangzhou University of Chinese Medicine,Guangzhou 510000,ChinaInstitute of Molecular Rhythm and Metabolism,Guangzhou University of Chinese Medicine,Guangzhou 510000,ChinaInstitute of Molecular Rhythm and Metabolism,Guangzhou University of Chinese Medicine,Guangzhou 510000,ChinaInstitute of Molecular Rhythm and Metabolism,Guangzhou University of Chinese Medicine,Guangzhou 510000,ChinaInstitute of Molecular Rhythm and Metabolism,Guangzhou University of Chinese Medicine,Guangzhou 510000,ChinaHebei Geo-Environment Monitoring Institute,Shijiazhuang 050021,ChinaInstitute of Molecular Rhythm and Metabolism,Guangzhou University of Chinese Medicine,Guangzhou 510000,ChinaDepartment of Public Health and Preventive Medicine,School of Medicine,Jinan University,Guangzhou 510632,China

liver diseases,alcoholicberberineintestinesintestinal-specific nuclear receptor subfamily 1 group D member 1

liver diseases,alcoholicberberineintestinesintestinal-specific nuclear receptor subfamily 1 group D member 1

《中医杂志(英文版)》 2026 (4)

788-797,10

Supported by the Project for Young Qihuang Scholars of the National Administration of Traditional Chinese MedicineChina Postdoctoral Science Foundation-Founded Project:Mechanism Study of Circadian Rhythm in Allergic Rhinitis(No.2024M760666)the Scientific Research Platforms and Projects of Guangdong Higher Education Institutions-founded Project:Circadian Controlled Disease and Innovative Drug Investigation Team(No.2023KCXTD009)

10.19852/j.cnki.jtcm.2026.04.002

评论